Annual EBITDA
-$8.04 M
-$302.00 K-3.90%
December 31, 2021
Summary
- As of February 10, 2025, KMPH annual EBITDA is -$8.04 million, with the most recent change of -$302.00 thousand (-3.90%) on December 31, 2021.
- During the last 3 years, KMPH annual EBITDA has risen by +$42.76 million (+84.18%).
Performance
KMPH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$6.13 M
+$18.41 M+75.03%
September 30, 2022
Summary
- As of February 10, 2025, KMPH quarterly EBITDA is -$6.13 million, with the most recent change of +$18.41 million (+75.03%) on September 30, 2022.
- Over the past year, KMPH quarterly EBITDA has dropped by -$4.44 million (-262.97%).
Performance
KMPH Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$34.82 M
-$4.44 M-14.61%
September 30, 2022
Summary
- As of February 10, 2025, KMPH TTM EBITDA is -$34.82 million, with the most recent change of -$4.44 million (-14.61%) on September 30, 2022.
- Over the past year, KMPH TTM EBITDA has dropped by -$26.36 million (-311.73%).
Performance
KMPH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
KMPH EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.9% | -263.0% | -311.7% |
| 3 y3 years | +84.2% | -229.8% | -96.4% |
| 5 y5 years | +78.5% | +24.0% | -96.4% |
KMPH EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | +294.5% | +300.5% | -7820.6% | at low |
| 5 y | 5-year | +3.9% | +141.1% | -197.4% | +300.5% | -7820.6% | at low |
| alltime | all time | +60.1% | +532.0% | -152.5% | +366.7% | -7820.6% | +56.5% |
KemPharm EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$6.13 M(-75.0%) | -$34.82 M(+14.6%) |
| Jun 2022 | - | -$24.54 M(+1480.2%) | -$30.38 M(-6836.4%) |
| Mar 2022 | - | -$1.55 M(-40.3%) | $451.00 K(-105.7%) |
| Dec 2021 | -$8.04 M(+3.9%) | -$2.60 M(+54.0%) | -$7.88 M(-6.8%) |
| Sep 2021 | - | -$1.69 M(-126.8%) | -$8.46 M(+5.7%) |
| Jun 2021 | - | $6.29 M(-163.7%) | -$8.00 M(-31.0%) |
| Mar 2021 | - | -$9.88 M(+211.0%) | -$11.60 M(+117.1%) |
| Dec 2020 | -$7.74 M(-60.1%) | -$3.18 M(+157.3%) | -$5.34 M(-14.8%) |
| Sep 2020 | - | -$1.24 M(-145.8%) | -$6.27 M(+1890.8%) |
| Jun 2020 | - | $2.70 M(-174.4%) | -$315.00 K(-97.0%) |
| Mar 2020 | - | -$3.63 M(-11.6%) | -$10.67 M(-39.8%) |
| Dec 2019 | -$19.38 M(-61.8%) | -$4.11 M(-187.0%) | -$17.73 M(+4.3%) |
| Sep 2019 | - | $4.72 M(-161.7%) | -$16.99 M(-51.6%) |
| Jun 2019 | - | -$7.65 M(-28.4%) | -$35.07 M(-1.4%) |
| Mar 2019 | - | -$10.69 M(+217.1%) | -$35.56 M(-27.7%) |
| Dec 2018 | -$50.80 M | -$3.37 M(-74.8%) | -$49.18 M(-9.7%) |
| Sep 2018 | - | -$13.36 M(+64.1%) | -$54.49 M(+10.8%) |
| Jun 2018 | - | -$8.14 M(-66.5%) | -$49.19 M(+7.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$24.31 M(+180.2%) | -$45.65 M(+27.7%) |
| Dec 2017 | -$37.32 M(+304.3%) | -$8.68 M(+7.7%) | -$35.76 M(+1.9%) |
| Sep 2017 | - | -$8.06 M(+75.0%) | -$35.10 M(-9.1%) |
| Jun 2017 | - | -$4.60 M(-68.1%) | -$38.60 M(+72.8%) |
| Mar 2017 | - | -$14.41 M(+79.6%) | -$22.34 M(+142.1%) |
| Dec 2016 | -$9.23 M(-81.5%) | -$8.03 M(-30.6%) | -$9.23 M(+0.2%) |
| Sep 2016 | - | -$11.56 M(-199.1%) | -$9.21 M(+48.9%) |
| Jun 2016 | - | $11.66 M(-994.2%) | -$6.19 M(-86.7%) |
| Mar 2016 | - | -$1.30 M(-83.7%) | -$46.44 M(-8.0%) |
| Dec 2015 | -$49.97 M(+130.5%) | -$8.01 M(-6.2%) | -$50.45 M(-3.9%) |
| Sep 2015 | - | -$8.54 M(-70.1%) | -$52.49 M(+3.0%) |
| Jun 2015 | - | -$28.59 M(+437.9%) | -$50.94 M(+102.1%) |
| Mar 2015 | - | -$5.32 M(-47.1%) | -$25.20 M(+16.2%) |
| Dec 2014 | -$21.68 M(+331.8%) | -$10.05 M(+43.9%) | -$21.68 M(+86.4%) |
| Sep 2014 | - | -$6.98 M(+144.6%) | -$11.63 M(+150.2%) |
| Jun 2014 | - | -$2.85 M(+59.1%) | -$4.65 M(+159.1%) |
| Mar 2014 | - | -$1.79 M | -$1.79 M |
| Dec 2013 | -$5.02 M | - | - |
FAQ
- What is KemPharm annual EBITDA?
- What is the all time high annual EBITDA for KemPharm?
- What is KemPharm annual EBITDA year-on-year change?
- What is KemPharm quarterly EBITDA?
- What is the all time high quarterly EBITDA for KemPharm?
- What is KemPharm quarterly EBITDA year-on-year change?
- What is KemPharm TTM EBITDA?
- What is the all time high TTM EBITDA for KemPharm?
- What is KemPharm TTM EBITDA year-on-year change?
What is KemPharm annual EBITDA?
The current annual EBITDA of KMPH is -$8.04 M
What is the all time high annual EBITDA for KemPharm?
KemPharm all-time high annual EBITDA is -$5.02 M
What is KemPharm annual EBITDA year-on-year change?
Over the past year, KMPH annual EBITDA has changed by -$302.00 K (-3.90%)
What is KemPharm quarterly EBITDA?
The current quarterly EBITDA of KMPH is -$6.13 M
What is the all time high quarterly EBITDA for KemPharm?
KemPharm all-time high quarterly EBITDA is $11.66 M
What is KemPharm quarterly EBITDA year-on-year change?
Over the past year, KMPH quarterly EBITDA has changed by -$4.44 M (-262.97%)
What is KemPharm TTM EBITDA?
The current TTM EBITDA of KMPH is -$34.82 M
What is the all time high TTM EBITDA for KemPharm?
KemPharm all-time high TTM EBITDA is $451.00 K
What is KemPharm TTM EBITDA year-on-year change?
Over the past year, KMPH TTM EBITDA has changed by -$26.36 M (-311.73%)